Authorization for Initiative on Keeping Pharmaceuticals Affordable and Accessible

The authorization will support two to three grants over the next 12 months. Priority areas for grantmaking will initially include the following:
* Documenting and tracking spending and price trends and identifying key drivers.
* Assisting federal and state agencies in their role as pharmaceutical purchasers.
* Comparing prices and policies internationally.
* Documenting industry practices that affect price transparency for purchasers and consumers.
* Advancing policy options related to drug patents and drug exclusivity.

Projects funded by this appropriation will position the Fund as a source of objective information about pharmaceutical spending and contribute to the national dialogue around this issue.